Exercise vs. Topical Diclofenac vs. PRP
NCT05877027 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 82
Last updated 2025-09-04
Summary
Osteoarthritis, the most common type of arthritis, is a chronic and degenerative joint disease. It has been reported to affect more than 300 million adults and elderly individuals worldwide. The joint most commonly affected by osteoarthritis is the knee joint and this condition is called gonarthrosis.
The goal of treatment is to reduce symptoms and ultimately slow the progression of the disease with various treatment options throughout the course of the disease.Current clinical studies prepared by the working groups of the International Osteoarthritis Research Society (OARSI) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) According to the guidelines, treatment typically includes physiotherapy interventions with the use of non-steroidal anti-inflammatory drugs (NSAIDs) and analgesics, including intra-articular injections of corticosteroids. Exercise-oriented physiotherapy is one of the main approaches for the conservative treatment of gonarthrosis. The curative clinical effect of exercise therapy on pain and functional disability in gonarthrosis is important.
The use of PRP in the treatment of gonarthrosis is based on the ability of platelets to release biologically active proteins and promote tissue healing. Since the cartilage tissue mainly affected in gonarthrosis has low healing potential, this feature of platelets becomes more important for the target tissue. Existing studies show that PRP is superior to hyaluronic acid in intermediate and initial gonarthrosis; on the other hand, less satisfactory results are reported in severe gonarthrosis, similar to viscosupplementation.
Topically or orally administered NSAIDs form the backbone of pharmacological treatment in gonarthrosis.
It is seen that both exercise, PRP and topical NSAID agents are among the recommendations in the treatment of gonarthrosis. However, there is insufficient evidence regarding the superiority and therapeutic efficacy of these three treatment approaches. The aim of this study is to determine the effectiveness of "exercise", "PRP" and "NSAID-specific topical agents" in the treatment of patients with gonarthrosis; pain, function, quality of life, and patient satisfaction.
Conditions
- Gonarthrosis
Interventions
- OTHER
-
Exercise
The first 3 weeks of the exercise program will include range of motion exercises, isometric and isotonic strengthening exercises for the muscles around the knee and hip, and stretching exercises. In the following 3 weeks, resistance strengthening exercises and closed kinetic chain exercises will be added to the program.
- OTHER
-
Topical Diclofenac
They will apply it around the knee joint 4 days a week, 2 times a day (every 12 hours), morning and evening for 6 weeks.
- OTHER
-
Platelet-Rich-Plasma (PRP)
8 ml of blood will be taken from each patient in tubes containing 0.9 ml of 3.2% sodium citrate. Swing-out rotor (open-swing type) will be placed in the centrifuge with the tubes facing each other. After centrifugation, 2.5 cc of PRP product will be collected from each tube and the resulting PRP will be administered to patients by injection under sterile conditions.
Sponsors & Collaborators
-
Istanbul University - Cerrahpasa
lead OTHER
Principal Investigators
-
Sezen Karabörklü Argut, PhD · Istanbul University - Cerrahpasa
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 40 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-20
- Primary Completion
- 2025-03-18
- Completion
- 2025-05-18
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Efficacy of Mesotherapy Added to Intra-articular Platelet-rich Plasma (PRP) in Patients With Knee Osteoarthritis
NCT05329116 ·Status: UNKNOWN ·Phase: NA
-
Platelet Rich Plasma (PRP) as a Treatment for Knee Osteoarthritis PRP as a Treatment for Knee Osteoarthritis
NCT01270412 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Autologous Plasma Rich in Growth Factors (PRGF) Treating the Symptomatic Knee OA
NCT00782197 ·Status: COMPLETED ·Phase: PHASE4
-
Teriparatide as a Chondroregenerative Therapy in OA
NCT03072147 ·Status: COMPLETED ·Phase: PHASE2
-
Knee Osteoarthritis: Platelet Rich Plasma or Hyaluronic Acid
NCT03801564 ·Status: UNKNOWN ·Phase: NA
-
Assessment and Comparison of Efficacy of Intra-Articular PRP and Corticosteroid in First CMC Joint OA Treatment
NCT06657300 ·Status: COMPLETED ·Phase: PHASE4
-
Intraarticular Injections of Platelet-rich Plasma in Pain's Treatment of the Osteoarthritic Knee
NCT02448407 ·Status: COMPLETED ·Phase: PHASE3
-
Intra-Articular Platelet Rich Plasm Use in Osteoarthritis of Knee.
NCT03086759 ·Status: COMPLETED ·Phase: PHASE4
-
Bilateral Knee Osteoarthritis: Intra-articular Injection of Filtered Autologous Adipose Tissue Versus Placebo
NCT04567732 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study Comparing a Generic Diclofenac Sodium Topical Gel, 1% to Voltaren in the Treatment of Subjects With Osteoarthritis of the Knee
NCT02121002 ·Status: COMPLETED ·Phase: PHASE3
-
Knee Osteoarthritis Treatment With Platelet-rich Plasma
NCT05824806 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Platelet-Rich Plasma and the Effects of NSAIDs on Pain and Functional Scores in Knee Osteoarthritis
NCT05742763 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Serum Nesfatin-1 and Human Cartilage Glycoprotein-39 Levels in Knee Osteoarthritis
NCT06254976 ·Status: COMPLETED ·Phase: NA
-
Intraarticular Platelet-rich Plasma Injections Versus Corticosteroid Injections in Primary Knee Osteoarthritis
NCT01923909 ·Status: WITHDRAWN ·Phase: PHASE4
-
FiH Safety and Feasibility Study Assessing Intra-articular Administration of aeGF in Patients With Knee Osteoarthritis
NCT06690710 ·Status: RECRUITING ·Phase: PHASE1
-
Dry Needling and Exercise Program in Osteoarthritis
NCT06816940 ·Status: COMPLETED ·Phase: NA
-
PRP-HA Versus HA in Knee Osteoarthritis
NCT05076526 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Intra Articular Injection of Microfat and PRP in Knee Osteoarthritis
NCT04352075 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Platelet Rich Plasma Injection for Knee Osteoarthritis
NCT04454164 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Efficacy of Micro-fragmented Adipose Tissue Injection for Knee Osteoarthritis.
NCT03379168 ·Status: COMPLETED ·Phase: NA
-
Analgesic Efficacy And Safety of Tanezumab Added On To Diclofenac SR In Patients With Osteoarthritis Of The Knee Or Hip
NCT00864097 ·Status: TERMINATED ·Phase: PHASE3
-
Platelet Rich Plasma Versus Corticosteroids in Knee Osteoarthritis Pain
NCT06703970 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate Arthroplasty Specimens for Osteoarthritis of the Knee and Hip
NCT03949673 ·Status: TERMINATED ·Phase: PHASE2
-
Fenugreek Wraps in Osteoarthritis of the Knee
NCT03528824 ·Status: COMPLETED ·Phase: NA
-
Preparation Rich in Growth Factors (PRGF) Treatment for Osteoarthritis of the Knee
NCT00728611 ·Status: COMPLETED ·Phase: PHASE2/PHASE3